MEETINGS - Injectable Products: formulation challenges, solutions and technology trends (UK) October 2005:
This article was originally published in Clinica
Management Forum will host Injectable Products: formulation challenges, solutions and technology trends at The Institute of Directors, London, on October 24-25. Topics will include: US regulatory requirements for drug-device combination products; design of safety injection devices for home and hospital use; current trends in the market for self-injection devices; and pre-filled devices intended for end customer use. To register, contact: Management Forum Ltd, 48 Woodbridge Road, Guildford GU1 4RJ, UK. Fax: +44 (0) 1483 536424; email: email@example.com; www.management-forum.co.uk
You may also be interested in...
UK start-up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country. See what Iceni’s CEO Rob Field said about it here.
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.